{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:17:41Z","timestamp":1788970661316,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.riam.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:09:30Z","timestamp":1781136570000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and treatment patterns of isavuconazole in real-world use in Mexico: A retrospective study of 25 patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Monserrat","family":"Mass\u00f3-P\u00e1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guzm\u00e1n-Tepetla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana","family":"Valencia-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaivet","family":"Toledo-Vigueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Rosario","family":"Ordaz-Cu\u00e9llar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Barrag\u00e1n-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aguilar-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2026.03.002_bib0110","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.riam.2026.03.002_bib0115","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.riam.2026.03.002_bib0120","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1097\/HS9.0000000000000320","article-title":"Isavuconazole in hematological patients: results of a real-life multicentre observational SEIFEM study","volume":"3","author":"Cattaneo","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.riam.2026.03.002_bib0125","series-title":"Comisi\u00f3n de autorizaci\u00f3n sanitaria direcci\u00f3n ejecutiva de autorizaci\u00f3n de productos y establecimientos obtenci\u00f3n de modificaci\u00f3n de product hu\u00e9rfano, aprobado [Internet]. Gob.mx","year":"2019"},{"key":"10.1016\/j.riam.2026.03.002_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.riam.2026.03.002_bib0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2026.03.002_bib0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/jof6040324","article-title":"Isavuconazole: mechanism of action, clinical efficacy, and resistance","volume":"6","author":"Ellsworth","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.riam.2026.03.002_bib0145","series-title":"In the EPAR summary for the public","article-title":"Cresemba (isavuconazole)","year":"2015"},{"key":"10.1016\/j.riam.2026.03.002_bib0150","series-title":"StatPearls [Internet]","article-title":"Antifungal ergosterol synthesis inhibitors [actualizado 2024 Mar 1]","author":"Herrick","year":"2025"},{"key":"10.1016\/j.riam.2026.03.002_bib0155","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.riam.2026.03.002_bib0160","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2026.03.002_bib0165","doi-asserted-by":"crossref","first-page":"e0017722","DOI":"10.1128\/aac.00177-22","article-title":"New perspectives on antimicrobial agents: isavuconazole","volume":"66","author":"Lewis","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2026.03.002_bib0170","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomized controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.riam.2026.03.002_bib0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2026.03.002_bib0180","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s40121-024-01064-4","article-title":"Effectiveness, safety, and patterns of real-world isavuconazole use in Europe (2015\u20132019)","volume":"13","author":"Neofytos","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.riam.2026.03.002_bib0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/jof9050583","article-title":"Fungal infections in the ICU during the COVID-19 pandemic in Mexico","volume":"9","author":"Roman-Montes","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.riam.2026.03.002_bib0190","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/jac\/dkad143","article-title":"Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"78","author":"Stemler","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.riam.2026.03.002_bib0195","series-title":"Abstract from the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023; April 15","article-title":"Effectiveness, safety, and patterns of real-world isavuconazole use\u2014a retrospective medical record review study of patients with invasive aspergillosis","author":"Sung","year":"2023"},{"key":"10.1016\/j.riam.2026.03.002_bib0200","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/mmy\/myab009","article-title":"COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City","volume":"59","author":"V\u00e9lez Pintado","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.riam.2026.03.002_bib0205","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.riam.2026.03.002_bib0210","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140626000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140626000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:53:25Z","timestamp":1788969205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140626000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1130140626000227"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2026.03.002","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and treatment patterns of isavuconazole in real-world use in Mexico: A retrospective study of 25 patients","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}